🔎 Trials Near Me

Hjem › Akut bifænotypisk leukæmi › Texas › Dallas

Akut bifænotypisk leukæmi kliniske forsøg i Dallas, TX

6 studier for Akut bifænotypisk leukæmi søger deltagere på steder i og omkring Dallas (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.

Officiel studietekst (engelsk)

Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

RekruttererFase 2
  • Medical City Dallas Hospital, Dallas
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas
365 Days · Alle køn · Opdateret 25. sep. 2026 · NCT06317662

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

RekruttererFase 3
  • Medical City Dallas Hospital, Dallas
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas
365 Days – 25 Years · Alle køn · Opdateret 25. aug. 2026 · NCT03959085

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

RekruttererFase 1/2
  • Medical City Dallas Hospital, Dallas
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Op til 22 år · Alle køn · Opdateret 25. aug. 2026 · NCT04726241

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

RekruttererFase 1
  • UT Southwestern/Simmons Cancer Center, Dallas
Alder 1 til 30 · Alle køn · Opdateret 3. aug. 2026 · NCT06177067

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

RekruttererFase 1/2
  • University of Texas(UT) Southwestern-Children's Medical Center, Dallas
Alder 12 til 95 · Alle køn · Opdateret 15. apr. 2026 · NCT04329728

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

RekruttererFase 1
  • University of Texas, Southwestern, Dallas
Alder 1 til 21 · Alle køn · Opdateret 6. dec. 2024 · NCT05476770

Akut bifænotypisk leukæmi forsøg i andre byer

Andre studier i Dallas

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.